The U.S. Food and Drug Administration on Thursday granted an early approval to Sarepta Therapeutics Inc's gene therapy for Duchenne muscular dystrophy (DMD).
from Latest https://ift.tt/36ukzv5
US FDA gives early approval to Sarepta's DMD gene therapy
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment